Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device ...

Repurposing treatments to treat multiple conditions is quicker, safer, and less expensive than developing new ways to manage ...

By Daniella Parra Acumen Pharmaceuticals said it will present new research on its Alzheimer’s treatment candidate at the International Conference on Alzheimer’s and Parkinson’s Diseases 2026 in ...

The Alzheimer’s field is being turned on its head as mounting evidence points to the disease beginning outside the brain many ...

Those of us in our 50s or 60s may have concerns about Alzheimer’s Disease or may already be caring for aging relatives ...

Cognito raised $105 million as it awaits trial data that it hopes will convince the FDA to authorize its Alzheimer’s treatment device.

Scientists have long searched for ways to treat Alzheimer’s disease, the most common form of dementia. Chief among these ...

MMI is starting FDA-approved human trials for its tiny robot to use needles the size of eyelashes to help clear waste from the brains of Alzheimer’s patients.

Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...

By Carole Tanzer Miller HealthDay ReporterSATURDAY, March 7, 2026 (HealthDay News) — No matter how much you brush, floss and ...

The country is facing a coming wave of dementia for its ageing population, and is investing in research into drugs, ...

A once-daily dose of a medication, which averaged 195 mg, produced blood levels significantly lower than those typically ...